| 摘要 |
<P>PROBLEM TO BE SOLVED: To provide a therapeutic agent for FXR-related diseases and adiponectin-related diseases. <P>SOLUTION: A composition comprising chalcones as active ingredients is used for treating diseases which can be effectively treated by activation of farnesoid X receptor (FXR) or enhancement of adiponectin. <P>COPYRIGHT: (C)2007,JPO&INPIT |
